Feedback / Questions
remlifanserin (ACP-204) - Acadia Pharma
https://www.ctad-alzheimer.com/sites/www.ctad-alzheimer.com/files/medias/documents/CTAD26_Preliminary%20Program_website-July06.pdf
Sanjeev Pathak1; Clive Ballard2; Jeffrey Cummings3; Samantha Friend4; Becky Howell1; Christine Murphy4; Xiaoshu Feng1; Mona Darwish1; Bryan Dirks1
Aug 3, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next